LEADER 02307cam a2200517 a 4500001    9976911343506421
005    20231120141000.0
006    m     o  d f
007    cr b||||||||||
008    130625s1979    mdua    ob   f000 0 eng c
027    CAS no. 139-94-6
035    ocn850513320
035    (NjP)7691134-princetondb
035     |z(NjP)Voyager7691134
040    GPO |beng |cGPO |dMvI
042    pcc
043    n-us---
049    DOCS
074    0507-G-12 (online)
086 0  HE 20.3159/2:146
088    NCI-CG-TR-146
090    Electronic Resource
245 00 Bioassay of nithiazide for possible carcinogenicity / |cCarcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health ; conducted by Litton Bionetics, Inc.
264  1 Bethesda, Md. : |bU. S. Dept. of Health, Education, and Welfare, Public Health Service, National Institutes of Health, |c1979.
300    1 online resource (104 unnumbered pages) : |billustrations.
336    text |btxt |2rdacontent
337    computer |bc |2rdamedia
338    online resource |bcr |2rdacarrier
490 1  National Cancer Institute carcinogenesis technical report series ; |vno. 146
500    Title from title screen (viewed on June 25, 2013).
500    "CAS no. 139-94-6."
500    "NCI-CG-TR-146."
500    DHEW publication ; no. (NIH) 79-1702.
500    Conducted for the Carcinogenesis Testing Program, National Cancer Institute, by Litton Bionetics, Inc., Bethesda, Md.
504    Includes bibliographical references (page [43-44]).
650  0 Carcinogens.
650  0 Veterinary drugs |xToxicology.
710 2  Litton-Bionetics, inc.
710 2  National Institutes of Health (U.S.)
710 2  Carcinogenesis Testing Program (U.S.)
710 2  National Cancer Institute (U.S.). |bDivision of Cancer Cause and Prevention.
776 08  |iPrint version:Litton-Bionetics, inc. |tBioassay of nithiazide for possible carcinogenicity |w(OCoLC)14385934
830  0 National Cancer Institute carcinogenesis technical report series ; |vno. 146.
830  0 DHEW publication ; |vno. (NIH) 79-1702.
945    DOCS |cHE 20.3159/2:146
956 40  |uhttps://purl.fdlp.gov/GPO/gpo33552